Skip to main content

and
  1. No Access

    Article

    Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL

    Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma, and front line therapies have not improved overall outcomes since the advent of immunochemotherapy. By pairing DNA and gene expression data wi...

    Keenan T. Hartert, Kerstin Wenzl, Jordan E. Krull, Michelle Manske in Leukemia (2021)